Legal Representation
Attorney
Lisa M. Tittemore
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 8, 2021 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 8, 2021 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 19, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 17, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 17, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 17, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 10, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 7, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 12, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 12, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 23, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 4, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 30, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 23, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 23, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 23, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 17, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 17, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 13, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 19, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 5, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Housemark for pharmaceutical preparations, namely, pharmaceutical preparations for assessment, treatment, and prophylaxis of osteoarthritis, ophthalmic disease, pulmonary disease, liver disease, kidney disease, neurological disease, cognitive impairment, and mitochondrial health; pharmaceutical preparations for assessment, treatment, and prophylaxis for the health problems arising from the decline in organ systems, the immune system, and neurologic and cardiac function, respiratory tract infections, respiratory illness, immunosenescence, Parkinson's Disease, urinary tract infections, and heart disease; pharmaceutical preparations for assessment, treatment, and prophylaxis of diseases, disorders, and degenerative conditions associated with aging; pharmaceutical preparations for assessment, treatment, and prophylaxis of chronic diseases, conditions and functional disorders; pharmaceutical preparations for mitigation of aging, treatment of immunological diseases and degenerative conditions of the body, promotion of life extension, and restoration of bodily functions; pharmaceutical preparations for skin care; vaccines
Additional Information
Pseudo Mark
REST OR BIO
Classification
International Classes
005